Dia Egypt 2021 Webcasts
Hall A



Nashwa Saeed

Inceptor, a promising target for diabetes management



Amr El Meligy

 Epicardial adipose tissue an emerging biomarker in CVD




Nabil El Kafrawy 

Semaglutide once weekly Above & Beyond





Ibrahim Elebrashy 

IDegLira The Power of DUAL action




Salah Shelbaya 

Liraglutide 3 0 mg filling the gap in obesity management



Nabil El Naggar 

Multi receptor agonist for management 



Nabil El Kafrawy

 Novel Dual GIP GLP 1 receptor agonists




Nermine Sheriba 

SGLT 2 and DPP 4 inhibitors A complementary mechanism





Salah Shelbaya 

State of the art lecture Metformin beyond glycemic control




Magdy Helmy Megalla 

Enriching T2DM patients control




 Ibrahim Elebrashy 

VERIFY updates The value of numbers!





Opening Ceremony




Ahmed Bahaa 

Evidence based guidelines for diabetic kidney disease




Inas Sabry 

Continuous glucose monitoring in diabetes




Atef Bassiouny

Paresthesia feet Do not take it easy



Mohamed Selim

Contra Diabetics have different risks and should be risk stratified

 



Ibrahim Elebrashy

 Icosapent Ethyl 1gm a New era in management of Hypertriglyceridemia & uncovere




Yehia Ghanem 

Rosuvastatin Ezetimibe combination Hit the unmet Targets




Hossam Arafa Ghazi

Glycocalyx; a novel way to examine vascular system among patient with diabetes



 Azza Abdel Karim 

Obesity, antidiabetic drugs which is which !

 



Fawzy El Messllamy

Cross talk between diabetes and Covid 19

 



Mark Nabil 

Bariatric surgery role




Sherihane Abou El Yazzed

Diet and exercise role in diabetes remission




Salah El Halawani 

Conventional view of type 2diabetes or Remission of type 2 diabetes 1




Nabil El Kafrawy 

TREAT TO Goal A new Answer!




Salah Shelbaya 

Protection you need TOMORROW starts TODAY




Mohamed Loutfi 

Jardiance as a game changer for HFrEF Management




Salah Shelbaya 

Initiating Oral Therapy in type 2 Diabetes; Role of Sitagliptin




Salwa Seddik Hosny 

Trials of oral therapy for type 1 diabetes




Hesham El gayar 

Diabetes Journey at Later Stage… Why Sitagliptin




Hesham El Gayar 

Dapagliflozin Portfolio The unique glucose lowering drug for DM




Samir Naim Assaad 

Antidiabetic agents and Hormones




Aly Abdel Rehim 

Atherosclerosis, a lipid disease or an endothelial disease




Hany Hafez 

Inappropriate imaging referral in diabetes

 



Rasha Sobh

Obese Brain




Mohamed Zitoun 

Psychological aspects of Hypoglycemia living in the land of fear!





Noha Gaber 

Diabetes &inflammation; playing with fire




Mohamed Selim 

RAAS Inhibitors Fact Checking; beyond blood





Mohamed Abdel Raouf 

Sotagliflozin in T1DM what does the data say





Mona Abdel Salam 

Reactive hypoglycemia





Closing




Ibrahim Elebrashy

The importance of flu vaccine during the COVID pandemic




Nabil El Kafrawy 

Diabetic Patients with Dyslipidemia What is the Role of PCSK9 Inhibitors




Abbot symposium